DD · 10-Q · 2026Q2 · Full report
Acquisition / Partnership / Divestiture
DuPont de Nemours, Inc. · 2026-08-04 · Importance 65 · Surprise 60 · In source text
DuPont completed the Aramids Divestiture to Arclin on April 1, 2026, receiving approximately $1.2 billion of pretax cash, a $300 million note receivable, and $325 million of noncontrolling equity in Arclin. DuPont classified the Aramids business as discontinued operations for current and comparative periods. The Electronics Business had previously been separated into Qnity on November 1, 2025, and is also presented as discontinued operations.
Key facts
- On April 1, 2026, DuPont completed the sale of the Aramids business to Arclin for pre-tax cash proceeds of approximately $1.2 billion, a note receivable in the principal amount of $300 million, and a non-controlling common equity interest valued at $325 million. source
- Acquisition, integration and separation costs were $7 million for the three and six months ended June 30, 2026, primarily related to costs to achieve cost savings targets following the Aramids Divestiture and Electronics Separation. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | positive | realized | +5.7% | On April 1, 2026, DuPont completed the sale of the Aramids business to Arclin for pre-tax cash proceeds of approximately $1.2 billion, a… |
| assets | positive | realized | +1.5% | On April 1, 2026, DuPont completed the sale of the Aramids business to Arclin for pre-tax cash proceeds of approximately $1.2 billion, a… |
| assets | positive | realized | +1.4% | On April 1, 2026, DuPont completed the sale of the Aramids business to Arclin for pre-tax cash proceeds of approximately $1.2 billion, a… |